Page last updated: 2024-09-04

bazedoxifene and Insulin Sensitivity

bazedoxifene has been researched along with Insulin Sensitivity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, M; Barrera, J; Chambliss, KL; McDonald, JG; Mineo, C; Shaul, PW; Tanigaki, K; Thompson, B1
Lovre, D; Mauvais-Jarvis, F; Xu, B1

Reviews

1 review(s) available for bazedoxifene and Insulin Sensitivity

ArticleYear
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
    Journal of diabetes and its complications, 2017, Volume: 31, Issue:4

    Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen

2017

Other Studies

1 other study(ies) available for bazedoxifene and Insulin Sensitivity

ArticleYear
Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
    American journal of physiology. Endocrinology and metabolism, 2014, Aug-01, Volume: 307, Issue:3

    Topics: Abdominal Fat; Adiposity; Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Fatty Liver; Female; Indoles; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Ovariectomy; Selective Estrogen Receptor Modulators; Uterus

2014